JP2007211026A5 - - Google Patents

Download PDF

Info

Publication number
JP2007211026A5
JP2007211026A5 JP2007124042A JP2007124042A JP2007211026A5 JP 2007211026 A5 JP2007211026 A5 JP 2007211026A5 JP 2007124042 A JP2007124042 A JP 2007124042A JP 2007124042 A JP2007124042 A JP 2007124042A JP 2007211026 A5 JP2007211026 A5 JP 2007211026A5
Authority
JP
Japan
Prior art keywords
dna plasmid
papillomavirus
particles
capsid protein
oral administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007124042A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007211026A (ja
JP4472724B2 (ja
Filing date
Publication date
Priority claimed from CN01118003A external-priority patent/CN1114690C/zh
Application filed filed Critical
Publication of JP2007211026A publication Critical patent/JP2007211026A/ja
Publication of JP2007211026A5 publication Critical patent/JP2007211026A5/ja
Application granted granted Critical
Publication of JP4472724B2 publication Critical patent/JP4472724B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007124042A 2001-05-15 2007-05-09 パピロマウイルス偽ウイルス及びその調製方法 Expired - Fee Related JP4472724B2 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN01118003A CN1114690C (zh) 2001-05-15 2001-05-15 乳头瘤假病毒及其制备方法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2001321828A Division JP4511090B2 (ja) 2001-05-15 2001-10-19 Ｄｎａプラスミドワクチン用アジュバンド及びその調製方法

Publications (3)

Publication Number Publication Date
JP2007211026A JP2007211026A (ja) 2007-08-23
JP2007211026A5 true JP2007211026A5 (https=) 2008-10-23
JP4472724B2 JP4472724B2 (ja) 2010-06-02

Family

ID=4662911

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2001321828A Expired - Fee Related JP4511090B2 (ja) 2001-05-15 2001-10-19 Ｄｎａプラスミドワクチン用アジュバンド及びその調製方法
JP2007124042A Expired - Fee Related JP4472724B2 (ja) 2001-05-15 2007-05-09 パピロマウイルス偽ウイルス及びその調製方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2001321828A Expired - Fee Related JP4511090B2 (ja) 2001-05-15 2001-10-19 Ｄｎａプラスミドワクチン用アジュバンド及びその調製方法

Country Status (4)

Country Link
US (3) US6878541B2 (https=)
JP (2) JP4511090B2 (https=)
CN (1) CN1114690C (https=)
WO (1) WO2002092796A1 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120164173A1 (en) * 2001-05-15 2012-06-28 Liang Qiao Papilloma Pseudovirus and Preparation
CN1114690C (zh) * 2001-05-15 2003-07-16 乔良 乳头瘤假病毒及其制备方法
AU2006236905B2 (en) 2005-04-15 2010-06-03 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods and compositions for producing an enhanced immune response to a human papillomavirus immunogen
HUE030437T2 (en) * 2007-05-08 2017-05-29 Us Health Papillomavirus pseudoviruses for detection and therapy of tumors
EP3427755B1 (en) 2009-04-13 2020-10-21 INSERM - Institut National de la Santé et de la Recherche Médicale Hpv particles and uses thereof
WO2011039646A2 (en) 2009-09-30 2011-04-07 Inserm (Institut National De La Sante Et De La Recherche Medicale) Papilloma virus -like particles for targeted gene delivery
NZ599543A (en) 2009-10-30 2014-02-28 Ntf Therapeutics Inc Improved neurturin molecules
WO2013119877A1 (en) 2012-02-07 2013-08-15 Aura Biosciences, Inc. Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells
MX356107B (es) 2012-02-16 2018-05-15 Atyr Pharma Inc Histidil-arnt sintetasas para tratar enfermedades autoinmunes e inflamatorias.
MX385842B (es) 2013-09-18 2025-03-18 Aura Biosciences Inc Conjugados de partículas de tipo virus y uso de las mismas.
KR20180083868A (ko) 2015-10-30 2018-07-23 알레타 바이오쎄라퓨틱스, 인크. 종양 형질도입용 조성물 및 방법
WO2017075440A1 (en) 2015-10-30 2017-05-04 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Targeted cancer therapy
JP7115982B2 (ja) 2015-10-30 2022-08-09 アレタ・バイオセラピューティクス・インコーポレイテッド 癌の治療のための組成物及び方法
US10751398B2 (en) * 2016-10-07 2020-08-25 Loyola University Chicago Inflammasome activators and methods of use to treat tumors
IL269986B2 (en) 2017-04-12 2024-06-01 Aura Biosciences Inc Targeted combination therapy
KR102797824B1 (ko) 2017-06-23 2025-04-17 버이뮨 아이엔씨. 키메라 바이러스-유사 입자 및 면역 반응의 항원-특이적 재지향자로서의 이의 용도
EP3706783A1 (en) 2017-11-06 2020-09-16 The United States of America, as represented by the Secretary, Department of Health and Human Services Cancer treatment utilizing pre-existing microbial immunity
WO2019096796A1 (en) 2017-11-14 2019-05-23 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Non-human papillomaviruses for gene delivery in vitro and in vivo
SG11202106931PA (en) 2018-12-27 2021-07-29 Verimmune Llc Conjugated virus-like particles and uses thereof as anti-tumor immune redirectors
WO2026055208A1 (en) 2024-09-04 2026-03-12 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Virus-like particle conjugates comprising photoactivatable dye compounds and methods of making and using the same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19526752C2 (de) * 1995-07-21 1997-08-07 Lutz Prof Dr Gissmann Hocheffiziente Bildung von Papillomavirusähnlichen Partikeln
FR2749323B1 (fr) * 1996-06-04 1998-07-10 Pasteur Merieux Serums Vacc Pseudo-particules virales utiles en tant que vecteur de delivrance d'acide nucleique
JP2000515741A (ja) * 1996-07-17 2000-11-28 アメリカ合衆国 感染性パピローマウイルス偽ウイルス粒子
ES2572628T3 (es) * 1997-09-05 2016-06-01 Medimmune, Inc. Método in vitro para desmontaje/remontaje de partículas análogas al virus del papiloma humano (VLP)
GB9806666D0 (en) * 1998-03-27 1998-05-27 Stanley Margaret Antigen preparation and use
CN1241636A (zh) * 1999-07-05 2000-01-19 第一军医大学珠江医院 抗hpv16e6核酶质粒及其在人乳头瘤病毒与肿瘤治疗中的应用
GB0007231D0 (en) * 2000-03-24 2000-05-17 Chiron Spa Modified rna for gene delivery
CN1114690C (zh) 2001-05-15 2003-07-16 乔良 乳头瘤假病毒及其制备方法

Similar Documents

Publication Publication Date Title
JP2007211026A5 (https=)
Al-Halifa et al. Nanoparticle-based vaccines against respiratory viruses
Chavda et al. mRNA-based vaccine for COVID-19: they are new but not unknown!
RU2017137357A (ru) Быстрорастворяющаяся лекарственная форма пероральной вакцины, в которой используют крахмал
JP2011521654A5 (https=)
JP2013537518A5 (https=)
JP2013533747A5 (https=)
CN106659777A8 (zh) 免疫原性组合产品
JP2008529558A5 (https=)
JP2010522698A5 (https=)
JP2008530245A5 (https=)
JP2017524682A5 (https=)
JP2016539946A5 (https=)
JP2009515831A5 (https=)
Zhang et al. PH-controlled release of antigens using mesoporous silica nanoparticles delivery system for developing a fish oral vaccine
JP2008505857A5 (https=)
Rosales-Mendoza et al. Nanovaccines
JP2013518052A5 (https=)
JP2010506926A5 (https=)
Hashemzadeh et al. Vaccines based on virus-like nano-particles for use against Middle East Respiratory Syndrome (MERS) coronavirus
JP2008514203A5 (https=)
JP2006502228A5 (https=)
Zhang et al. Nanotechnology-driven advances in intranasal vaccine delivery systems against infectious diseases
Wong et al. COVID-19 Vaccine: Review of the Mechanism of Action of Different Types of Vaccine Li-Ann Wong*, Christina Gertrude Yap, Nowrozy Kamar Jahan, Naganathan Pillai.
Uddin et al. A novel formulation strategy to deliver combined DNA and VLP based HPV vaccine